Replies to post #160066 on Biotech Values

[DewDiligence]

Speaking of FoB collaborations…there’s a new one between India’s Strides and Pfenex (a private US company) to develop a Betaseron FoB:

http://www.pharmatimes.com/Article/13-04-17/Cipla_launches_Enbrel_biosimilar_in_India.aspx

[jq1234]

HSP-Celltrion Rituxan Biosimilar: Not according to BioCentrury, it is just timeline change:

http://www.biocentury.com/dailynews/company/2013-04-18/celltrion-amends-timeline-for-rituximab-biosimilar